Drug Detail

Information about Belinostat

Generic Name
Belinostat
IND
PXD101
Brand Name (US)
Manufacturer
Topo/Target A/S
Drug Type
HDAC Inhibitor
Delivery
Intravenous
Approval Status
Phase 2
Indications
Overall Strategy
GIST cell based
Strategy
Unblock cell death genes
Drug Category
HDAC inhibitor


Links

 

Topotarget's webpage about belinostat
   

Trials of this drug

  

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
   

Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed